首页> 外文期刊>ACS medicinal chemistry letters >Discovery and Design of First Benzylamine-Based Ligands Binding to an Unlocked Conformation of the Complement Factor D
【24h】

Discovery and Design of First Benzylamine-Based Ligands Binding to an Unlocked Conformation of the Complement Factor D

机译:基于苄胺的配体的发现与设计与补体因子D解锁构象的结合

获取原文
获取原文并翻译 | 示例
       

摘要

Complement Factor D, a serine protease of the S1 family and key component of the alternative pathway amplification loop, represents a promising target for the treatment of several prevalent and rare diseases linked to the innate immune system. Previously reported FD inhibitors have been shown to bind to the FD active site in its self-inhibited conformation characterized by the presence of a salt bridge at the bottom of the S1 pocket between Asp189 and Arg218. We report herein a new set of small-molecule FD ligands that harbor a basic S1 binding moiety directly binding to the carboxylate of Asp189, thereby displacing the Asp189-Arg218 ionic interaction and significantly changing the conformation of the self-inhibitory loop.
机译:补体因子D,S1家族的丝氨酸蛋白酶和替代途径扩增回路的关键组分,代表了治疗与先天免疫系统相关的几种普遍和罕见疾病的有前途的靶标。 先前报道的FD抑制剂已被证明在其自抑制构象中与FD活性位点结合,其特征在于ASP189和ARG218之间的S1袋底部存在盐桥。 我们在本文中报告了一组新的小分子FD配体,其含有直接结合ASP189的羧酸盐的基本S1结合部分,从而使ASP189-ARG218离子相互作用置换并显着改变自我抑制回路的构象。

著录项

  • 来源
    《ACS medicinal chemistry letters》 |2018年第5期|共6页
  • 作者单位

    Novartis Pharma AG Institutes for BioMedical Research Novartis Campus CH-4056 Basel Switzerland;

    Novartis Pharma AG Institutes for BioMedical Research Novartis Campus CH-4056 Basel Switzerland;

    Novartis Pharma AG Institutes for BioMedical Research Novartis Campus CH-4056 Basel Switzerland;

    Novartis Pharma AG Institutes for BioMedical Research Novartis Campus CH-4056 Basel Switzerland;

    Novartis Pharma AG Institutes for BioMedical Research Novartis Campus CH-4056 Basel Switzerland;

    Novartis Pharma AG Institutes for BioMedical Research Novartis Campus CH-4056 Basel Switzerland;

    Novartis Pharma AG Institutes for BioMedical Research Novartis Campus CH-4056 Basel Switzerland;

    Novartis Pharma AG Institutes for BioMedical Research Novartis Campus CH-4056 Basel Switzerland;

    Novartis Pharma AG Institutes for BioMedical Research Novartis Campus CH-4056 Basel Switzerland;

    Novartis Pharma AG Institutes for BioMedical Research Novartis Campus CH-4056 Basel Switzerland;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;化学;
  • 关键词

    Alternative complement pathway; factor D inhibitors; fragment-based drug discovery; structure-based design;

    机译:替代补体途径;因子D抑制剂;基于片段的药物发现;基于结构的设计;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号